As part of pharmaphorum’s eye-on-innovation interview series, Paul Tunnah speaks to Merck Biopharma’s vice president of innovation Ulrich Betz on how the company is celebrating its 350th
Ahead of his talk at EyeforPharma Barcelona next week, Medscape’s Ben Greenberg talks to pharmaphorum about the hype surrounding technology, and offers ideas about how to identify meaningful innovation.
The capabilities of artificial intelligence are advancing and its 'third wave' offers the ability to analyse enormous sets of data, identify patterns, and generate algorithms to explain them, t
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
